Genomma Lab

Mexico City, Mexico Founded: 1996 • Age: 30 yrs
OTC and generic drugs are manufactured and distributed.
Request Access

About Genomma Lab

Genomma Lab is a company based in Mexico City (Mexico) founded in 1996 by Rodrigo Herrera Aspra.. The company has 1,600 employees as of December 31, 2024. Genomma Lab has completed 2 acquisitions, including Bufferin and Prestige Brands. Genomma Lab offers products and services including Medications and Personal Care Items.

  • Headquarter Mexico City, Mexico
  • Employees 1600 as on 31 Dec, 2024
  • Founders Rodrigo Herrera Aspra
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Genomma Lab Internacional Sab De Cv Class B
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $897.15 M (USD)
    12.99
    as on Dec 31, 2024
  • Net Profit
    $71.83 M (USD)
    45.48
    as on Dec 31, 2024
  • EBITDA
    $205.85 M (USD)
    24.38
    as on Dec 31, 2024
  • Latest Funding Round
    $126 M (USD), Debt – Conventional

    May 12, 2018

  • Investors
  • Employee Count
    1600

    as on Dec 31, 2024

  • Investments & Acquisitions
    Bufferin

    & 1 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Genomma Lab

Genomma Lab is a publicly listed company on the BMV with ticker symbol LAB/B in Mexico, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: BMV · Ticker: LAB/B . Sector: Health technology · Mexico

Products & Services of Genomma Lab

Genomma Lab offers a comprehensive portfolio of products and services, including Medications and Personal Care Items. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Medications for various ailments such as pain and hydration are provided through innovative formulations.

Items for skin and hair care are supplied to support daily health maintenance.

Funding Insights of Genomma Lab

  • Total Funding
  • Total Rounds 1
  • Last Round Debt – Conventional — $126.0M
  • First Round

    (12 May 2018)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2018 Amount Debt – Conventional - Genomma Lab Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Genomma Lab

Genomma Lab has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Bufferin and Prestige Brands. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Hand sanitizer and aspirin products are manufactured by Bufferin.
1996
Over-the-counter healthcare products are provided for consumer health needs.
1996
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Genomma Lab

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Genomma Lab Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Genomma Lab

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Genomma Lab

When was Genomma Lab founded?

Genomma Lab was founded in 1996 and raised its 1st funding round 22 years after it was founded.

Where is Genomma Lab located?

Genomma Lab is headquartered in Mexico City, Mexico.

Who is the current CEO of Genomma Lab?

Jorge Luis Brake Valderrama is the current CEO of Genomma Lab.

How many employees does Genomma Lab have?

As of Dec 31, 2024, the latest employee count at Genomma Lab is 1,600.

What is the annual revenue of Genomma Lab?

Annual revenue of Genomma Lab is $897.15M as on Dec 31, 2024.

What does Genomma Lab do?

Genomma Lab was founded in 1996 and is headquartered in Mexico City, Mexico. Over-the-counter and generic drugs, along with personal care products, are produced and distributed by the company. These items address conditions such as acne, dandruff, warts, colitis, wrinkles, migraines, vaginal health issues, hemorrhoids, scars, and alopecia. Operations focus on the pharmaceutical and consumer health sectors.

What products or services does Genomma Lab offer?

Genomma Lab offers Medications and Personal Care Items.

Is Genomma Lab publicly traded?

Yes, Genomma Lab is publicly traded on BMV under the ticker symbol LAB/B.

How many acquisitions has Genomma Lab made?

Genomma Lab has made 2 acquisitions, including Bufferin, and Prestige Brands.

What is Genomma Lab's ticker symbol?

The ticker symbol of Genomma Lab is LAB/B on BMV.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available